Latest News

The Abbott system allows physicians to gather up to 14 days' worth of glucose data without the patient having to interact with any device, or even calibrate it.
During the plenary session on the first day of the fall meeting of the National Association of Accountable Care Organizations, CMS' Sean Cavanaugh discussed the outcomes of the Medicare ACO programs and members of 2 successful ACOs joined him on stage to provide their input.
A new study has found that after adjusting for changes in screening, there was a decrease in incidence of all grades of cervical intraepithelial neoplasia (CIN) for women 15- to 19-years old, and CIN grade 2 in women 20- to 24-years old.
Data show that the biggest factor affecting distribution of uninsured rates was whether a state expanded Medicaid. Even with that limitation, uninsured rates have reached historic lows. The trouble is, only about one-fourth of Americans know this, and more have moved on to issues that affect them personally, such as the cost of premiums or high deductibles.
A recent clinical trial found that SD-101, a new proprietary topical allantoin cream, can help treat epidermolysis bullosa. The study is a breakthrough in EB treatment and research as thus far, treatment options for this rare and painful rare connective tissue disorder are limited.
During the most recent web-based seminar of The American Journal of Managed Care’s ACO & Emerging Healthcare Delivery Coalition, experts discussed a digital test that can help primary care physicians assess patients’ cognitive abilities and detect impairment sooner.
Dr Leonard Fromer on Personalized Versus Precision Medicine
Personalized medicine looks at a patient’s genome, but precision medicine takes more of their social and individual determinants into account, said Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
What we're reading, September 29, 2016: as part of the bill to prevent a government shutdown, the Senate has finally approved Zika virus funding; electronic health record breaches skyrocketed from 2014 to 2015; and California passes "right to try" law for terminally ill patients.
The company's announcement notably does not use the term "artificial pancreas," although the technology is a considerably more significant advance from the 530G threshold suspend device of 2013. When the description "artificial pancreas" was attached to that product, the term was met with howls of protest from the type 1 diabetes community.
A study published in the journal Cancer has discovered that a 2012 recommendation for prostate cancer screening did not change physician behavior.
Dr Ally-Khan Somani: Mohs Surgery Is a Gold Standard
Mohs surgery is generally the gold standard for rare and more aggressive tumors because of the way the surgeon can ensure the roots of the tumor are gone and because the technique keeps the hole small, said Ally-Khan B. Somani, MD, PhD, at the 25th European Academy of Dermatology and Venereology Congress.
Plenary lecturer Stephen I. Katz, MD, PhD, director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and adjunct investigator in the Dermatology Branch of the National Cancer Institute opened the 25th European Academy of Dermatology and Venereology Congress in Vienna with a discussion on past and future advances in dermatology.
Dr Aleksandar Krunic Discusses the Reimbursement Issues of Mohs Surgery
Reimbursement issues surrounding Mohs surgery are getting worse, which provides a challenge for surgeons who would perform the procedure, explained Aleksandar L. Krunic, MD, PhD, during the 25th European Academy of Dermatology and Venereology Congress.
Horizon Blue Cross Blue Shield's annual Patient-Centered Summit covered efforts by the state to expand naloxone access, provide peer support for those rescued from an opioid overdose, and the insurer's prevention practices.

From the Journals

The authors propose statewide programs that would expand the Prescription Drug Monitoring Program for all medications—not just opiates—in order to reduce outpatient medication errors.
Second of 2 parts: Coverage of the first half of the session appeared in the May issue of Evidence-Based Diabetes Management.1
Second of 2 Parts: See Part 1, in Evidence-Based Diabetes Management, coverage of Patient-Centered Diabetes Care 2016.
This study conducted a cost-benefit analysis of appointment-based medication synchronization for improving adherence in patients on chronic medications for hypertension, hyperlipidemia, and diabetes.
For some patients newly diagnosed with type 2 diabetes, skipping metformin monotherapy and going straight to fixed-dose combinations with a DPP-4 inhibitor or an SGLT2 inhibitor makes sense, evidence shows.
Compared with Japan, the United States has substantially less geographic variation in surgical outcomes, but it has higher variation in cost.
Two competing insulin / GLP-1 combinations, one from Sanofi and the other from Novo Nordisk, are under review at FDA.
Outpatient surgeries in the United States account for roughly 7% of annual healthcare expenditures. To exploit substantial opportunities to improve the value of outpatient surgical care, the authors composed an evidence-based care delivery composite for national discussion and pilot testing.
This article details strategies based on principles from psychology and economics that health systems may use to align with physicians.
Compendia
Diabetes Compendium
HCV Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium
Managed Care Cast
Managed Care Cast
Healthcare 2020

NEW! Focus on 2020: What does the Future of Healthcare Hold?

Most Popular

Upcoming Partner Events
October 19-20, 2016
Scottsdale, AZ
October 18-19, 2016
Philadelphia, PA
October 18-19, 2016
Philadelphia, PA

AJMC Strategic Alliance

$vacMongoViewPlus$